Nonresectable Adrenocortical Carcinoma
1 clinical trials · Condition
◉ Watch Nonresectable Adrenocortical Carcinoma
| Record | Firm | Date |
|---|---|---|
| Phase II Trial of ZD1839 (Iressa) in Patients With Nonresectable Adrenocortical Carcinoma (ACC) (NCT00215202) | Dartmouth-Hitchcock Medical Center | 2004-08-01 |
Track Nonresectable Adrenocortical Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.